Preparation method and application of injectable cross-linked hyaluronic acid microspheres for beauty
The preparation of crosslinked hyaluronic acid microspheres through W/O/W type compound milk system solved the problems of uneven crosslinking degree and irregular particles, and obtained microspheres with uniform particle size and high mechanical strength, suitable for beauty filling , achieving long-term beauty effects.
Patent Information
- Application Number
- CN202411130646.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-26
AI Technical Summary
In the prior art, the preparation method of crosslinking hyaluronic acid gel has problems such as uneven crosslinking degree, irregular particle shape and uneven particle size, which may cause redness, swelling and pain during injection, and biocompatibility and water retention. The performance is not ideal and cannot meet the needs of long-term beauty filling.
Using W/O/W compound milk microsphere preparation system, hyaluronic acid and crosslinking agent as internal aqueous phase, and organic solvent of polyester biopolymer membrane material as oil phase, through high-speed stirring and low-temperature crosslinking reaction , uniform crosslinked microspheres were formed, and the outer coated film and unreacted crosslinking agent were removed by washing to obtain crosslinked hyaluronic acid microspheres with good mechanical strength and elasticity.
Crosslinked hyaluronic acid microspheres with uniform crosslinking degree, uniform particle size distribution, high mechanical strength and strong anti-enzymatic lysis ability are achieved, reducing injection side reactions, improving the long-term effect of beauty filling, and suitable for drug-carrying microspheres Ball and beauty filling field.
Smart Images

Figure CN119015497A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of biomedical materials, and relates to a method for preparing a cross-linked hyaluronic acid filler for injection, and in particular to a method for preparing a hyaluronic acid microsphere long-acting filler for medical cosmetic injection. Background Art
[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] Human beings’ pursuit of beauty is an eternal topic. As people age, human aging is a reality that cannot be ignored, and anti-aging or delaying aging has become the trend of the times. Human aging includes the face, buttocks, chest and other parts. For example, the characteristics of facial aging mainly include soft tissue loss, collagen loss, decreased skin hydration, etc., which in turn cause fine lines and wrinkles on the face. In order to combat this irreversible aging phenomenon, injectable filling technology has emerged to fill sunken skin or stimulate muscle and collagen regrowth through foreign bodies, such as sodium hyaluronate, collagen, etc. Among them, sodium hyaluronate is the most widely used. However, due to the poor stability of natural sodium hyaluronate hydrogel, sensitivity to hyaluronidase and free radicals, short retention time in the body, poor mechanical strength and other deficiencies, it is usually chemically modified and cross-linked, thereby obtaining a series of new sodium hyaluronate gels with biological activity and functionality. In order to achieve long-term filling effects, people have also tried to use synthetic biomaterials, such as polylactic acid and polycaprolactone, which have the advantages of good biocompatibility, anticoagulant, non-toxicity and low immunity, but there are still certain injection risks, such as redness, swelling, maltoma, allergic inflammation, etc. Therefore, the need for a safe and reliable filler is a key scientific issue in the medical beauty injection industry.
[0004] As a traditional medical and aesthetic injectable material, sodium hyaluronate is a polysaccharide naturally present in human tissues. It is highly compatible with the physiological environment of the human body and has almost no risk of causing allergic or rejection reactions. After injection, it will be gradually absorbed and metabolized by the human body, thus giving it adjustability and reversibility, so that it can be adjusted or modified according to personal needs during the medical and aesthetic process. Functionalization or cross-linking of sodium hyaluronate is one of the reliable ways to achieve its long-term effectiveness. Cross-linked sodium hyaluronate gel has been studied for many years at home and abroad, and there are products on the market, such as Restylane, Juvederm and other brands. The main preparation method of cross-linked hyaluronic acid gel is that hyaluronic acid reacts with a cross-linking agent under alkaline conditions to form a gel. The obtained block gel is usually mechanically crushed or pressed through a sieve to obtain different particle size specifications. The cross-linked hyaluronic acid gel prepared in this way has problems such as uneven cross-linking degree, irregular particle morphology and uneven particle size. It is easy to cause side effects such as redness and swelling due to surface irregularity when used for facial filling. In addition, the particles are of different sizes, which causes a certain injection resistance, causing pain or destroying the user's experience. The microspherization of cross-linked hyaluronic acid gel is an effective way to solve this problem. The cross-linked hyaluronic acid microspheres are round and spherical, with a smooth surface without edges and corners and good fluidity. They improve the patient experience and greatly reduce the occurrence of side effects of facial filling. Cross-linked hyaluronic acid microspheres are a three-dimensional structure. After implantation into the body, they are surrounded by the body's phagocytes and giant cells, becoming a three-dimensional cell growth support carrier, which is conducive to the growth of fibroblasts and stimulates collagen production, so that the sunken areas are gradually filled. In addition, the proliferation of cellulose in the dermis produces the desired cosmetic effect. As time goes by, the dermis thickens and the filled area is completely replaced by new autologous tissue, resulting in a long-lasting cosmetic effect.
[0005] At present, there are two methods for preparing hyaluronic acid microspheres: one is to solidify and shape after emulsification and granulation, and the other is to crosslink and granulate first. The patent with publication number EP2225281 describes a method for preparing crosslinked hyaluronic acid microspheres in an emulsion. The microspheres obtained by the method have uniform morphology and particle size distribution between 1nm and 1μm, but the crosslinked hyaluronic acid microspheres obtained at last do not carry out effective oil phase residual and crosslinking agent residual control measures, and biocompatibility and water retention performance are still unsatisfactory, and there are problems such as product instability, which cannot meet market demand well. CN104387600A discloses a method for preparing composite crosslinked sodium hyaluronate gel microspheres for facial injection, first adding hyaluronic acid gel to emulsion for emulsification and then adding crosslinking agent to the emulsion for crosslinking, this method requires a large amount of crosslinking agent, and the crosslinking agent is difficult to penetrate into the gel and leak outside the microsphere, resulting in low crosslinking efficiency, uneven crosslinking, or the existence of crosslinking phenomenon (adhesion) between balls, and the mechanical properties of the microspheres are not high, and they are easy to break. CN10318902A discloses a method for preparing a composite cross-linked sodium hyaluronate gel microsphere for facial injection, the method will be broken, washed and filtered by the secondary cross-linked sodium hyaluronate gel to obtain cross-linked sodium hyaluronate microspheres, the operation is difficult, and it is difficult to achieve microsphere preparation. CN115770528A discloses a method for preparing a cationized hyaluronic acid microsphere, hyaluronic acid substances are wrapped with wall materials, and then the cationized microspheres are obtained by aminolysis reaction and applied to textile fabric finishing agents, but the problem of preparing medical beauty injection hyaluronic acid microspheres is not involved, and it is a simple physical aggregate (i.e. non-chemical cross-linking system). CN117018288A discloses a method for preparing a hyaluronic acid microsphere for injection, the method adopts a simple emulsified form, there is leakage of cross-linking agent or cross-linking between microspheres, and then the problems such as poor distribution of microspheres and uneven particle size. Summary of the invention
[0006] In order to solve the above problems, the present invention provides a method for preparing cosmetic injectable cross-linked hyaluronic acid microspheres. The present invention uses cross-linked hyaluronic acid microspheres to construct a W / O / W type emulsion microsphere preparation system with hyaluronic acid (salt) and a cross-linking agent as the inner water phase and an organic solvent solution of a polyester biopolymer film material as the oil phase. In this uniform cross-linked microenvironment, the reaction conditions are mild and controllable, which can effectively prevent the cross-linking agent in the inner water phase from leaking out and reduce its dosage, and the cross-linking degree is uniform, and the obtained microspheres have higher mechanical strength and good elasticity.
[0007] On the one hand, the outer wall material (polyester) of the invention acts as a fixing agent and separator, forming a W / O / W "micro-region (closed chamber)" in the early stage of ball formation, and the cross-linking agent cross-links the hyaluronic acid, effectively preventing the leakage of the cross-linking agent and effectively solving the adhesion between the microspheres. On the other hand, the outer wall material acts as a sacrificial material, which is removed by washing with an organic solution after the microspheres are formed, and at the same time, the residual cross-linking agent is also removed, achieving multiple goals at one stroke; and the quality of the obtained cross-linked hyaluronic acid microspheres is better than that of the microspheres made by retaining the outer wall material.
[0008] In order to achieve the above object, the present invention adopts the following technical solution:
[0009] The first aspect of the present invention provides a method for preparing cosmetic injectable cross-linked hyaluronic acid microspheres, comprising:
[0010] Dissolving hyaluronic acid (salt) in water and adding a cross-linking agent to obtain an inner water phase, wherein the mass concentration of hyaluronic acid (salt) in the inner water phase is 1 to 10%;
[0011] Dissolving polyester biopolymers in an organic solvent to form an oil phase, wherein the mass concentration of the polymers in the oil phase is 1 to 5%;
[0012] The external water phase is a water solution containing a certain concentration of surfactant;
[0013] The pH of the inner water phase is adjusted to 11-13, and the oil phase is added, and a W / O type emulsion is obtained under high-speed stirring;
[0014] Under mechanical stirring conditions, adding the W / O type emulsion to the external water phase to obtain a W / O / W type double emulsion;
[0015] The W / O / W type emulsion is stirred at room temperature for 4 to 6 hours, and the organic solution is volatilized to obtain a polyester polymer-coated hyaluronic acid composite microsphere suspension; then stirred at low temperature, the cross-linking reaction is continued for 12 to 24 hours, and the mixture is allowed to stand and centrifuged to obtain hyaluronic acid composite microspheres; the composite microspheres are washed to remove the outer polymer coating film and unreacted cross-linking agent, and freeze-dried to obtain cross-linked hyaluronic acid microspheres.
[0016] In some embodiments, the hyaluronic acid (salt) is one or more of hyaluronic acid, sodium hyaluronate, zinc hyaluronate or calcium hyaluronate.
[0017] In some embodiments, the cross-linking agent is selected from one or more of sodium trimetaphosphate, 1,4-butanediol glycidyl ether, polyethylene glycol glycidyl ether, and divinyl sulfone (DVS); preferably 1,4-butanediol glycidyl ether.
[0018] In some embodiments, the mass ratio of the cross-linking agent to the hyaluronic acid (salt) is 1:4-10.
[0019] In some embodiments, the polyester biopolymer is one or more of polylactic acid, polycaprolactone, polyglycolic acid, and polylactic acid-glycolic acid copolymer, preferably polylactic acid.
[0020] In some embodiments, the organic solvent is one of dichloroethane, n-hexane, and ethyl acetate.
[0021] In some embodiments, the volume ratio of the inner water phase to the oil phase is 1:2-5.
[0022] In some embodiments, the surfactant is one or more of Span-80, Tween-20, and polyvinyl alcohol;
[0023] In some embodiments, the mass concentration of the surfactant in the external water phase is 1-5%.
[0024] In some embodiments, the volume ratio of the W / O type emulsion to the external aqueous phase is 1:4-8;
[0025] In some embodiments, the hyaluronic acid composite microspheres are washed with an organic solvent and water;
[0026] In some embodiments, the organic solvent is one or more of ethylene dichloride, cyclohexane, and ethyl acetate.
[0027] More specifically, they include:
[0028] (1) dissolving hyaluronic acid (salt) in deionized water and adding a crosslinking agent to obtain an inner water phase, wherein the mass concentration of hyaluronic acid (salt) in the inner water phase is 1 to 10%;
[0029] (2) Using polyester biopolymer as membrane material, dissolving it in an organic solvent to form an oil phase, wherein the mass concentration of the polymer in the oil phase is 1 to 5%;
[0030] (3) using a deionized water solution containing a certain concentration of surfactant as the external water phase;
[0031] (4) adjusting the pH of the inner aqueous phase to 11-13 with a 2 mol / L sodium hydroxide solution, and rapidly adding the solution to the oil phase, and stirring at a high speed of 1000-2000 rpm to obtain a W / O emulsion;
[0032] (5) Add the above W / O emulsion to the external aqueous phase under stirring at a speed of 600 to 900 rpm to prepare a W / O / W emulsion; stir at room temperature for 4 to 6 hours to volatilize the organic solution to obtain a polyester polymer-coated hyaluronic acid composite microsphere suspension; slowly stir at low temperature and continue the cross-linking reaction for 12 to 24 hours; stand and centrifuge to obtain hyaluronic acid composite microspheres; then wash with an organic solvent and deionized water to remove impurities such as the outer polymer coating film of the composite microspheres and unreacted cross-linking agent, and freeze-dry to obtain cross-linked hyaluronic acid microspheres with a particle size of 20 to 60 μm.
[0033] The second aspect of the present invention provides cosmetic injectable cross-linked hyaluronic acid microspheres prepared by the above method, with a particle size of 20 to 60 μm. The reaction conditions of the present invention are mild and controllable, effectively preventing the adhesion and agglomeration of the microspheres, uniform particle size distribution, controllable and adjustable size, uniform cross-linking degree, good mechanical strength and elasticity, strong resistance to enzymolysis, and conducive to maintaining in vivo for a longer time. It can be used in the field of drug-loaded microspheres and cosmetic filling, and has broad application prospects and market value.
[0034] The third aspect of the present invention provides the use of the cosmetic injectable cross-linked hyaluronic acid microspheres prepared by the above method in the field of drug-loaded microspheres and cosmetic filling.
[0035] The cross-linked hyaluronic acid microspheres prepared by the present invention can be used in the field of medical beauty and health. The freeze-dried cross-linked hyaluronic acid microspheres are uniformly dispersed in cross-linked hyaluronic acid, sodium hydroxymethyl cellulose (CMC) or a mixture of mannitol and sodium hydroxymethyl cellulose, and lidocaine hydrochloride is appropriately added to prepare an injectable medical beauty filler containing cross-linked hyaluronic acid microspheres, which is used for filling facial parts such as lips, cheeks, chins, or other parts of the body, and has the effects of repairing damaged skin, improving wrinkles, and moisturizing the skin.
[0036] Beneficial effects of the present invention
[0037] (1) The preparation method of injectable cross-linked hyaluronic acid microspheres provided by the present invention constructs a microsphere preparation system of a W / O / W type emulsion. On the one hand, the hyaluronic acid (salt) and the cross-linking agent in the inner aqueous phase are evenly distributed, providing an effective guarantee for high and uniform cross-linking; on the other hand, the oil phase forms a protective film layer, which effectively prevents the leakage of the cross-linking agent, improves its utilization efficiency, and effectively prevents the adhesion of microspheres or cross-linking between microspheres. The protective layer also protects the inner layer microspheres from being damaged by high shear forces, thereby improving the cross-linking degree of the microspheres.
[0038] (2) The preparation method of the injectable cross-linked hyaluronic acid microspheres provided by the present invention has stable process, strong operability, and is suitable for industrial production.
[0039] (3) The injectable cross-linked hyaluronic acid microspheres provided by the present invention have uniform particle size distribution, controllable and adjustable size, uniform cross-linking degree, good mechanical strength and elasticity, good flow phase, strong resistance to enzymatic hydrolysis, and are conducive to maintaining in vivo for a longer time. They can be used in the field of drug-loaded microspheres and cosmetic fillings, and have broad application prospects and market value.
[0040] (4) The preparation method of the present invention is simple, practical and easy to promote. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] The accompanying drawings constituting a part of the present invention are used to provide a further understanding of the present invention, and the exemplary embodiments of the present invention and their description are used to explain the present invention and do not constitute improper limitations on the present invention.
[0042] Figure 1 This is a microscope image of the cross-linked hyaluronic acid microspheres of Example 1;
[0043] Figure 2 This is a scanning electron microscope image of the cross-linked hyaluronic acid microspheres in Example 1. DETAILED DESCRIPTION
[0044] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used in the present invention have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0045] The present invention will be further described in detail below in conjunction with specific embodiments. It should be noted that the specific embodiments are intended to explain the present invention rather than to limit it.
[0046] Example 1
[0047] A method for preparing cosmetic injectable cross-linked hyaluronic acid microspheres comprises the following steps:
[0048] (1) Weigh 0.5 g of sodium hyaluronate and fully dissolve it in 10 mL of deionized water, add 1,4-butanediol glycidyl ether (0.1 g), stir and disperse evenly to form the inner aqueous phase;
[0049] (2) Weigh 0.4 g of polylactic acid and dissolve it in 20 mL of dichloroethane to form the oil phase;
[0050] (3) Weigh 2 g of polyvinyl alcohol and dissolve it in 200 mL of deionized water to form the external aqueous phase;
[0051] (4) The pH of the external aqueous phase was adjusted to ∼13 with a 2 mol / L sodium hydroxide solution, which was rapidly added to the oil phase and stirred at 1500 rpm for 5 min to obtain a W / O emulsion;
[0052] (5) Add the above W / O type emulsion to the external aqueous phase under stirring at a speed of 800 rpm to prepare a W / O / W type emulsion; stir at a speed of 600 rpm for 4 hours, and after the organic solution evaporates, obtain a polyester polymer-encapsulated hyaluronic acid composite microsphere suspension; then continue the cross-linking reaction for 24 hours; after the reaction is completed, stand and centrifuge to obtain hyaluronic acid composite microspheres; wash with dichloroethane and deionized water respectively, and freeze-dry to obtain cross-linked hyaluronic acid microspheres.
[0053] Example 2
[0054] A method for preparing cosmetic injectable cross-linked hyaluronic acid microspheres comprises the following steps:
[0055] (1) Weigh 0.8 g of zinc hyaluronate and fully dissolve it in 10 mL of deionized water, add polyethylene glycol glycidyl ether (0.1 g), stir and disperse evenly to form the inner aqueous phase;
[0056] (2) Weigh 0.3 g of polycaprolactone and dissolve it in 30 mL of n-hexane to form the oil phase;
[0057] (3) Weigh 5 g of Span-80 and dissolve it in 200 mL of deionized water to form the external aqueous phase;
[0058] (4) The pH of the external aqueous phase was adjusted to ∼12 with a 2 mol / L sodium hydroxide solution, which was rapidly added to the oil phase and stirred at 1200 rpm for 8 min to obtain a W / O emulsion;
[0059] (5) Add the above W / O emulsion to the external aqueous phase under stirring at 800 rpm to prepare a W / O / W emulsion; stir at 500 rpm for 5 h, and after the organic solution evaporates, obtain a polyester polymer-encapsulated hyaluronic acid composite microsphere suspension; then continue the cross-linking reaction for 20 h; after the reaction is completed, stand and centrifuge to obtain hyaluronic acid composite microspheres; wash with n-hexane and deionized water respectively to obtain cross-linked hyaluronic acid microspheres.
[0060] Example 3
[0061] A method for preparing cosmetic injectable cross-linked hyaluronic acid microspheres comprises the following steps:
[0062] (1) Weigh 1.0 g of hyaluronic acid and fully dissolve it in 10 mL of deionized water, add divinyl sulfone (0.2 g), stir and disperse evenly to form the inner aqueous phase;
[0063] (2) Weigh 1.0 g of poly(lactic acid-glycolic acid) copolymer and dissolve it in 40 mL of ethyl acetate to form the oil phase;
[0064] (3) Weigh 1.0 g of Span-80 and 1.5 g of Tween-20 and dissolve them in 200 mL of deionized water to form the external aqueous phase;
[0065] (4) The pH of the external aqueous phase was adjusted to ∼12 with a 2 mol / L sodium hydroxide solution, which was quickly added to the oil phase and stirred at 1800 rpm for 5 min to obtain a W / O emulsion;
[0066] (5) Add the above W / O emulsion to the external aqueous phase under stirring at 900 rpm to prepare a W / O / W emulsion; stir at 400 rpm for 6 hours to obtain a polyester polymer-encapsulated hyaluronic acid composite microsphere suspension after the organic solution evaporates; then continue the cross-linking reaction for 18 hours; after the reaction is completed, stand and centrifuge to obtain hyaluronic acid composite microspheres; wash with n-hexane and deionized water, respectively, and freeze-dry to obtain cross-linked hyaluronic acid microspheres.
[0067] Example 4
[0068] (1) adding sodium hyaluronate (molecular weight 1800K Da) into ultrapure water and fully dissolving it to obtain a sodium hyaluronate gel with a concentration of 1.5%;
[0069] (2) Add the cross-linked sodium hyaluronate microspheres prepared in Example 1 to the sodium hyaluronate gel to a content of 10%, then add lidocaine to a concentration of 2%, stir evenly, then package and freeze-dry to obtain a filler.
[0070] Comparative Example 1
[0071] The difference from Example 1 is that the n-hexane solution containing polylactic acid is not used as the external oil phase, but n-hexane is directly used as the external oil phase for emulsification, and the same conditions are used to form a W / O type emulsion, and then cross-link to prepare hyaluronic acid microspheres. The particle size of the obtained microspheres is uneven, some are large and some are small. After measurement by a laser particle size analyzer, two peaks appear, which are 10±4μm, 42±20μm, and 71±16μm, respectively, and some microspheres are adhered, and the microspheres are relatively soft and easy to be squeezed and broken.
[0072] Experimental Example 1
[0073] The cosmetic injectable cross-linked hyaluronic acid microspheres prepared in the above Examples 1-3 and Comparative Example 1 were characterized.
[0074] 1. Determination of particle size of injectable cross-linked hyaluronic acid microspheres: The prepared injectable cross-linked hyaluronic acid microspheres were measured by Malvern laser particle size analyzer. The particle size distribution was 20 to 60 μm. The results are listed in Table 1.
[0075] Microscope and scanning electron microscope measurements showed that the cross-linked hyaluronic acid microspheres were round and uniform in size. The microsphere structure and morphology were further verified by scanning electron microscope.
[0076] Table 1 Particle size distribution of cross-linked hyaluronic acid microspheres
[0077]
[0078] As can be seen from the description of Examples 1-3, the cross-linked hyaluronic acid microspheres prepared by the method of the present invention are round and uniform in size. As can be seen from the comparison between Example 1 and Comparative Example 1, the introduction of the wall material effectively solves the problem of microsphere adhesion and uneven particle size.
[0079] 2. Determination of the elastic modulus of injectable cross-linked hyaluronic acid microspheres: The oscillation compression deformation degree of the sample from 0.1% to 10% (1Hz, 25°C) was measured using a DHR2 rheometer. The elastic modulus E' values of the cross-linked hyaluronic acid microspheres prepared in Examples 1 to 3 were 183.58±21.27KPa, 172.73±16.27KPa and 129.46±13.95KPa, respectively, while the elastic modulus E' value of the microspheres prepared in Comparative Example 1 was 31.62±4.37KPa, which shows that the cross-linked hyaluronic acid microspheres prepared by the method of the present invention have higher mechanical properties. At the same time, it can be seen from the comparison of Example 1 and Comparative Example 1 that the introduction of the wall material effectively prevents the leakage of the cross-linking agent in the inner water phase and reduces its dosage, providing a stable "reaction microenvironment area" for the cross-linking of the hyaluronic acid microspheres, improving the cross-linking degree and cross-linking agent utilization rate of the hyaluronic acid microspheres, and thus significantly improving their mechanical properties.
[0080] 3. Stability of injectable cross-linked hyaluronic acid microspheres: The stability of HA-filled products depends on the degradation rate of endogenous HA enzymes after injection into the body, which in turn affects the long-term shaping effect. Enzyme dissolution experiment of cross-linked hyaluronic acid microspheres: Add hyaluronic acid microspheres dyed with toluidine blue (2%) to 300UHA enzyme solution (150U / mL), place them on a shaker and shake them slowly, take samples at different times to observe the enzymatic hydrolysis of the gel microspheres, and record the enzyme dissolution time. The experimental results show that the enzyme dissolution time of the cross-linked hyaluronic acid microspheres prepared in Examples 1 to 3 is 420min, 450min and 410min, respectively, which is significantly better than the enzyme dissolution time (240min) of Comparative Example 1. It can be seen that the morphology and size of the cross-linked hyaluronic acid microspheres have a significant effect on their stability. At the same time, it can be seen from the comparison of Example 1 and Comparative Example 1 that the introduction of wall materials effectively improves the cross-linking degree and anti-enzymatic ability of the hyaluronic acid microspheres.
[0081] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for preparing cosmetic injectable cross-linked hyaluronic acid microspheres, characterized in that: include: Dissolving hyaluronic acid (salt) in water and adding a cross-linking agent to obtain an inner water phase, wherein the mass concentration of hyaluronic acid (salt) in the inner water phase is 1 to 10%; Dissolving polyester biopolymers in an organic solvent to form an oil phase, wherein the mass concentration of the polymers in the oil phase is 1 to 5%; The external water phase is a water solution containing a certain concentration of surfactant; The pH of the inner water phase is adjusted to 11-13, and the oil phase is added, and a W / O type emulsion is obtained under high-speed stirring; Under mechanical stirring conditions, adding the W / O type emulsion to the external water phase to obtain a W / O / W type double emulsion; The W / O / W type emulsion is stirred at room temperature for 4 to 6 hours, and the organic solution is volatilized to obtain a polyester polymer-coated hyaluronic acid composite microsphere suspension; then stirred at low temperature, the cross-linking reaction is continued for 12 to 24 hours, and the mixture is allowed to stand and centrifuged to obtain hyaluronic acid composite microspheres; the composite microspheres are washed to remove the outer polymer coating film and unreacted cross-linking agent, and freeze-dried to obtain cross-linked hyaluronic acid microspheres.
2. The method for preparing the cosmetic injectable cross-linked hyaluronic acid microspheres according to claim 1, characterized in that: The hyaluronic acid (salt) is one or more of hyaluronic acid, sodium hyaluronate, zinc hyaluronate or calcium hyaluronate.
3. The method for preparing the cosmetic injectable cross-linked hyaluronic acid microspheres according to claim 1, characterized in that: The cross-linking agent is selected from one or more of sodium trimetaphosphate, 1,4-butanediol glycidyl ether, polyethylene glycol glycidyl ether, and divinyl sulfone; Alternatively, the mass ratio of the cross-linking agent to the hyaluronic acid (salt) is 1:4-10.
4. The method for preparing the cosmetic injectable cross-linked hyaluronic acid microspheres according to claim 1, characterized in that: The polyester biopolymer is one or more of polylactic acid, polycaprolactone, polyglycolic acid, and polylactic acid-glycolic acid copolymer.
5. The method for preparing the cosmetic injectable cross-linked hyaluronic acid microspheres according to claim 1, characterized in that: The organic solvent is one of dichloroethane, n-hexane and ethyl acetate.
6. The method for preparing the cosmetic injectable cross-linked hyaluronic acid microspheres according to claim 1, characterized in that: The volume ratio of the inner water phase to the oil phase is 1:2-5.
7. The method for preparing the cosmetic injectable cross-linked hyaluronic acid microspheres according to claim 1, characterized in that: The surfactant is one or more of Span-80, Tween-20, and polyvinyl alcohol; Alternatively, the mass concentration of the surfactant in the external water phase is 1 to 5%.
8. The method for preparing the cosmetic injectable cross-linked hyaluronic acid microspheres according to claim 1, characterized in that: The volume ratio of the W / O type emulsion to the external water phase is 1:4-8; Or, washing the hyaluronic acid composite microspheres with organic solvents and water; Alternatively, the organic solvent is one or more of ethylene dichloride, cyclohexane, and ethyl acetate.
9. The cosmetic injectable cross-linked hyaluronic acid microspheres prepared by the method according to any one of claims 1 to 8, characterized in that: The particle size is 20~60μm.
10. Use of the cosmetic injectable cross-linked hyaluronic acid microspheres prepared by the method according to any one of claims 1 to 8 in the field of drug-loaded microspheres and cosmetic filling.
Citation Information
Patent Citations
Preparation method of composite crosslinking sodium hyaluronate gel microspheres for facial injection
CN104387600A
Preparation method of cationized hyaluronic acid microspheres, obtained product and application
CN115770528A
Preparation method of hyaluronic acid microspheres for injection
CN117018288A
Crosslinked hyaluronic acid in emulsion
EP2225281A1
